Tentamus UK
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tentamus UK - overview
Established
2011
Location
-, -, UK
Primary Industry
Business Support Services
About
Tentamus UK is a leading provider of laboratory services, specializing in quality and safety solutions for multiple sectors including food, pharmaceuticals, and agriculture. Founded in 2011 in the UK, Tentamus Group operates as a laboratory service provider with a focus on testing and consulting across various sectors. The company was co-founded by Abgar Barseyten and Jochen Zoller and is led by CEO Abgar Barseyten. Tentamus has expanded its global footprint, establishing offices across Europe, North America, Asia, and beyond.
In July 2021, BC Partners will acquire Tentamus Group GmbH from Auctus Capital Partners. The transaction was completed in September 2021. As part of the transaction, BC Partners will fully acquire 100 percent stakes in the company. Tentamus Group specializes in laboratory services that focus on quality and safety across sectors such as Food & Feed, Pharmaceuticals, Nutraceuticals, Cosmetics, and Agriculture.
Their offerings include testing, auditing, and consulting services that ensure compliance with regulatory standards and promote human wellness. Leveraging advanced scientific methodologies and state-of-the-art equipment, Tentamus caters to a diverse clientele, supporting industries that prioritize consumer health. In the year 2022, Tentamus Group reported a revenue of USD 16. 34 mn and an EBITDA of USD -3.
30 mn. The company operates on a B2B model, generating revenue through service contracts, consulting agreements, and laboratory testing fees, which foster a steady stream of income from ongoing projects and per-project engagements.
Primary Industry
Business Support Services
Sub Industries
Consulting Services, Molecular Science, Genetics & Gene Therapy
Website
www.tentamus.com
Total Amount Raised
Subscriber access only
Tentamus UK - timeline of key events

Tentamus UK - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|
| Revenue (USD) | 11,495,227 | 13,747,395 | - | - | - |
| % Revenue Growth (YoY) | - | 19.6% | - | - | - |
| EBITDA (USD) | 912,759 | (3,889,689) | - | - | - |
| Operating Income (USD) | (265,561) | (5,438,776) | - | - | - |
| Operating Margin | (2.3%) | (39.6%) | - | - | - |
| % EBITDA Margin | 7.9% | (28.3%) | - | - | - |
| NET Income (USD) | (1,790,216) | (5,563,048) | - | - | - |
| % Net Margin | (15.6%) | (40.5%) | - | - | - |
Tentamus UK - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.